Skip to content

  1. Terremark's Latest Acquisition Offers Top-Flight Customer Growth • May 24, 2007

    It's been a quiet week for your CXS picks. But even with a shortage of news -- good or bad -- our positions have still managed to rally back from last week's sagging small-cap market.

    Read more…

  2. Lionbridge Blows Away Expectations • May 10, 2007

    Weak retail numbers are crushing the market today, but we still have three reasons to celebrate. To begin our week, we were delivered a nice earnings-season bump when CXS pick Lionbridge Technologies (LIOX:NASDAQ) reported record first-quarter earnings.

    Read more…

  3. Building a Diagnostic Monopoly • May 3, 2007

    Last week, an FDA panel unanimously recommended the approval of maraviroc, a new HIV treatment developed by Pfizer

    Read more…

  4. Terremark Triggers a "Buy" • May 2, 2007

    Since we last wrote to you, the price of Terremark Worldwide stock has backed off a little - right into our "buy" range. Now is the perfect time to pick up shares.

    Read more…

  5. May 2007 Issue • May 1, 2007

    Drug licensing, development, and government contracts are set to propel share prices Investing in biotech penny stocks can be a gamble. Many of these startup drug developers have a single “breakthrough” product that could take years to develop. These new drugs sometimes even run the risk of failing to secure FDA approval. Setbacks like these can [...]

    Read more…